Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease
2026年6月16日 更新者：Fatih Söke、Saglik Bilimleri Universitesi
Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease
The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are:
- Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence.
Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training.
Participants will:
- Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks.
- Participate in assessments at the study clinic before and after exercise training.
調査の概要
状態
募集
条件
研究の種類
介入
入学 (推定)
39
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Keçiören
-
Ankara、Keçiören、トルコ（Türkiye）、06010
- 募集
- Gulhane Faculty of Physiotherapy and Rehabilitation
-
コンタクト：
- Fatih SÖKE
- 電話番号：+90 312 567 15 00
- メール：fatih.soke@sbu.edu.tr
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
いいえ
説明
Inclusion Criteria:
- Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria.
- Being in stages 1-3 according to the Hoehn-Yahr Scale.
Exclusion Criteria:
- Presence of a neurological disease other than Parkinson's disease
- Cognitive impairment (Standardized Mini Mental Test score less than 24)
- Having undergone deep brain stimulation surgery
- Having a visual, auditory, or perceptual problem
- Having any orthopedic, rheumatological, or other condition that may affect walking and balance.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Single Task Training
Single task balance and walking training
|
Single task balance and walking exercises.
5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises with a 5-minute rest in between, and then a 5-minute cool-down period.
|
|
実験的：Motor-Motor Dual Task Training
Motor-motor dual task balance and walking training
|
Motor-motor dual task balance and walking exercises.
Motor-motor dual task balance and walking exercises.
5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with upper extremity motor tasks with a 5-minute rest in between, and then a 5-minute cool-down period.
|
|
実験的：Cognitive-Motor Dual Task Training
Cognitive-motor dual task balance and walking training
|
Cognitive-motor dual task balance and walking exercises.
Cognitive-motor dual task balance and walking exercises.
5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with cognitive tasks with a 5-minute rest in between, and then a 5-minute cool-down period.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3
時間枠：From enrollment to the end of training at 6 weeks
|
UPDRS is a reliable and valid scale that assesses cognitive skills, mood, daily living activities, motor skills, motor fluctuations, dyskinesias and autonomic dysfunction and is widely used in clinical studies and research in Parkinson's disease.
The motor symptoms section, which is the third section of this scale, will be used.
|
From enrollment to the end of training at 6 weeks
|
|
Hoehn & Yahr Scale
時間枠：From enrollment to the end of treatment at 6 weeks
|
It is a staging system that provides information quickly in determining the severity and symptoms of Parkinson's disease.
|
From enrollment to the end of treatment at 6 weeks
|
|
Single-Leg Stance Test
時間枠：From enrollment to the end of treatment at 6 weeks
|
This is a test method used to assess static balance.
The patient's preferred foot is raised without touching the supporting leg, and initially, the eyes are open.
The eyes are fixed towards the head, and the patient is expected to maintain their balance for 60 seconds.
The time the participant maintains their balance is recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
Functional Reach Test
時間枠：From enrollment to the end of treatment at 6 weeks
|
This test is designed to assess dynamic balance.
In the test, the participant is positioned sideways next to a wall, with their torso upright, the shoulder on the wall flexed to 90°, and the elbow fully extended.
The participant is then asked to make a fist with the same arm, and the position of the third metacarpal head is marked on the wall.
The participant reaches forward with their knees fully extended; the position of the third metacarpal head is marked again, and the participant returns to the starting position.
The difference between the two marks is measured with a tape measure.
|
From enrollment to the end of treatment at 6 weeks
|
|
10 Meter Walking Test
時間枠：From enrollment to the end of treatment at 6 weeks
|
Participants are asked to walk at normal walking speed for a distance of 10 meters and the time is recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
Motor-Motor Dual Task Cost of Walking
時間枠：From enrollment to the end of treatment at 6 weeks
|
To assess the motor-motor dual-task cost of walking, patients will perform the 10-meter walk test once as a single task and once while holding an empty plate on a tray in their hands. The dual-task cost will be calculated as a percentage using the following formula: [(Dual-task performance - Single-task performance)/ (Single-task performance) x 100] |
From enrollment to the end of treatment at 6 weeks
|
|
Cognitive-Motor Dual Task Cost of Walking
時間枠：From enrollment to the end of treatment at 6 weeks
|
To assess cognitive-motor dual-task cost of walking, patients will perform the 10-Meter Walk Test once as a single task and once as a dual-task test, counting backwards in increments of 7 from a three-digit number greater than 300. Dual-task cost will be calculated as a percentage using the following formula: [(Dual-task performance - Single-task performance)/ (Single-task performance) x 100] |
From enrollment to the end of treatment at 6 weeks
|
|
Timed Up and Go Test
時間枠：From enrollment to the end of treatment at 6 weeks
|
This test is used to assess functional mobility levels.
The test involves using a standard chair with the individual's knees flexed at 90° and their backrest against it.
The individual is asked to stand up from the chair, walk 3 meters, turn around, and then walk back to the chair and sit down.
The test begins with the command "walk," and the test duration is measured with a stopwatch and recorded in seconds.
|
From enrollment to the end of treatment at 6 weeks
|
|
Unified Parkinson's Disease Rating Scale (UPDRS) - PART 2
時間枠：From enrollment to the end of treatment at 6 weeks
|
It consists of thirteen items.
The assessment is based on anamnesis information regarding how the patient functions in various activities.
The presence of sensory complaints that may be related to tremor and parkinsonism is also included in this section as they can affect daily living activities.
Each item is evaluated using a scoring system between '0' and '4'.
|
From enrollment to the end of treatment at 6 weeks
|
|
Dual Task Questionnaire
時間枠：From enrollment to the end of treatment at 6 weeks
|
This test is used to assess the challenges encountered in daily tasks involving dual work.
It consists of 10 questions and is administered via face-to-face interview.
Each question is scored between 0 and 4. A score of "4" indicates frequent challenges, while a score of "0" indicates no challenges.
|
From enrollment to the end of treatment at 6 weeks
|
|
Trail Making Test
時間枠：From enrollment to the end of treatment at 6 weeks
|
It is used to assess executive functions and attention.
The test consists of two parts, A and B. In part A, the individual is asked to combine numbers from 1 to 25, and the completion time is recorded.
In part B, the individual completes a sequence where each number corresponds to a letter, and the completion time is recorded.
|
From enrollment to the end of treatment at 6 weeks
|
|
Activity-Specific Balance Confidence Scale
時間枠：From enrollment to the end of treatment at 6 weeks
|
This is a commonly used scale for assessing balance confidence.
The scale evaluates whether individuals believe they can perform daily living activities without losing their balance or becoming unsteady.
It consists of sixteen items.
Each item is scored between a minimum of "0" (unconfident) and a maximum of "100" (completely confident).
The base score is calculated by dividing the total score by 16.
Higher values indicate that the person feels good about their balance, while lower values are associated with an increased risk of falls.
|
From enrollment to the end of treatment at 6 weeks
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2026年6月15日
一次修了 (推定)
2026年9月1日
研究の完了 (推定)
2026年9月15日
試験登録日
最初に提出
2026年6月6日
QC基準を満たした最初の提出物
2026年6月6日
最初の投稿 (実際)
2026年6月11日
学習記録の更新
投稿された最後の更新 (実際)
2026年6月18日
QC基準を満たした最後の更新が送信されました
2026年6月16日
最終確認日
2026年6月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。